| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $122,386,828 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | P40OD010440 | Caenorhabditis Genetics Center | 000 | 15 | NIH | 3/23/2026 | $269,223 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01NS136490 | Ultrahigh-resolution Functional MRI of the Human Brain at 10.5 Tesla | 000 | 3 | NIH | 3/30/2026 | $553,548 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA310158 | Therapeutic Restoration of Cholangiocyte Primary Cilia via Microbiota-Derived Butyrate: A Novel Approach for Bile Duct Cancer | 000 | 1 | NIH | 4/9/2026 | $408,829 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | T35OD011118 | Veterinary Summer Scholars in Comparative Medicine | 000 | 13 | NIH | 4/9/2026 | $32,988 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30MH124404 | Dopaminergic modulation of nucleus accumbens during prospective and retrospective neuroeconomic decision making | 001 | 5 | NIH | 5/6/2026 | $288 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM162600 | Integrative Structural Biology in Viral RNA Synthesis Machinery | 000 | 1 | NIH | 5/1/2026 | $437,250 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01NS128039 | Architecture of inhibitory G protein signaling in the hippocampus | 000 | 4 | NIH | 4/8/2026 | $652,025 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01EB038350 | Safe, effective, and trustworthy AI for healthcare delivery organizations and populations across the United States | 000 | 1 | NIH | 3/30/2026 | $654,117 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI197293 | Molecular Investigation of Bacterial Penicillin-Binding Protein Activity and Inhibition | 001 | 1 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K99CA296729 | Paving the way for bystander T cell immunotherapies | 001 | 2 | NIH | 4/16/2026 | $11,394 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35HL177136 | Promoting weight-related health in the next generation of adolescents and young adults:A comprehensive program of research | 000 | 2 | NIH | 3/19/2026 | $994,197 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01AI159554 | Regulation of central tolerance and Treg development by recirculating Treg | 000 | 5 | NIH | 4/17/2026 | $387,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U54CA268069 | Center for Multiparametric Imaging of Tumor Immune Microenvironments | 001 | 5 | NIH | 4/16/2026 | $134,981 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K23DK146162 | Technology-Enhanced Adherence to Medication intervention for youth with Type 2 Diabetes (TEAM-T2D) | 000 | 1 | NIH | 3/19/2026 | $177,877 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM144029 | The C. elegans Germline: A Test Tube for Cell and Developmental Biology | 001 | 5 | NIH | 3/11/2026 | $44,950 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM128906 | Structural Biology Studies of a Large DNA Repair Complex | 000 | 8 | NIH | 5/4/2026 | $403,977 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL177306 | Understanding the genetic and immunologic basis of autoimmune hemolytic anemia (AIHA) in a novel canine model system | 000 | 2 | NIH | 4/9/2026 | $563,804 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01NS140244 | Determining the spatial limits and strengths of neurovascular coupling across layers of the cerebral cortex by using three-photon imaging of synapses, neurons and blood vessels | 000 | 2 | NIH | 4/7/2026 | $486,110 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U01AI174978 | Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal Infection | 000 | 4 | NIH | 4/7/2026 | $364,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01NS110613 | The effects of parkinsonism and deep brain stimulation on basal ganglia-thalamocortical circuitry during sleep-wake behavior | 000 | 8 | NIH | 4/6/2026 | $611,842 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM146957 | Methods for Selective Functionalization of (Hetero)arene Rings | 000 | 5 | NIH | 5/6/2026 | $374,236 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA290129 | Structural and dynamic basis for PRKACA-dependent signalopathies | 000 | 3 | NIH | 5/6/2026 | $525,605 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161283 | TERPENE: Titer Enhancement via Refactored Precursor pathways for Natural Produce Discovery | 000 | 1 | NIH | 5/7/2026 | $423,500 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30AI197932 | Development and Implementation of a Cost-Effective Diagnostic Algorithm to Reduce AIDS-Related Deaths among Hospitalized People with Advanced HIV Disease | 000 | 1 | NIH | 5/6/2026 | $55,114 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM139557 | Small RNA Regulation in Bacteria | 003 | 7 | NIH | 4/6/2026 | $498,447 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL177019 | Discovery and validation of single cell biomarkers for clinical outcome in sickle cell disease | 001 | 2 | NIH | 3/13/2026 | $18,550 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | P40OD010440 | Caenorhabditis Genetics Center | 002 | 15 | NIH | 5/6/2026 | $300,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA313195 | Single-Cell Signaling Network Profiling of Pooled CRISPR Screens by Mass Cytometry | 000 | 1 | NIH | 5/7/2026 | $406,325 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01DC023255 | Spectro-temporal interactions in electric and acoustic auditory perception | 000 | 1 | NIH | 3/13/2026 | $596,678 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31MH138042 | Perinatal depressive symptoms and infant self-regulation: Pathways through infant autonomic regulation and postnatal maternal sensitivity | 000 | 2 | NIH | 4/28/2026 | $26,464 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM162637 | Engineering Immunocompetent Systems for Modeling, Modulating, and Treating Inflammatory Diseases | 000 | 1 | NIH | 3/20/2026 | $398,144 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL165704 | Resolution of inflammation and atrial fibrillation | 001 | 4 | NIH | 4/24/2026 | $83,863 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30AA030900 | The role of stress, social support, and brain function on alcohol misuse in women | 000 | 4 | NIH | 4/16/2026 | $38,487 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | P30CA077598 | Cancer Center Support Grant | 001 | 28 | NIH | 4/17/2026 | $407,824 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA285608 | Targeting tumor cell mitochondria for the prevention and treatment of lung cancer | 001 | 2 | NIH | 4/17/2026 | $35,227 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | K01CA255417 | Electronic Nicotine Delivery Systems (ENDS) Use and Access in Florida's Tobacco Regulatory Environment | 001 | 6 | NIH | 4/16/2026 | $35,333 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HD116095 | Influences of Housing on Maternal and Infant Health: 30-year Follow-up of a Randomized Trial | 000 | 2 | NIH | 3/19/2026 | $616,521 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R35GM161202 | Dynamics of Motile Flagella in Fluid Media | 000 | 1 | NIH | 3/19/2026 | $373,737 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA299093 | Regulation of tumor associated macrophage function by STAT5 in breast cancer | 001 | 2 | NIH | 4/16/2026 | $50,557 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA270539 | Targeting early events in prostate cancer lineage plasticity | 001 | 4 | NIH | 4/16/2026 | $45,592 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F31AI197293 | Molecular Investigation of Bacterial Penicillin-Binding Protein Activity and Inhibition | 002 | 1 | NIH | 4/15/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | U01AI174978 | Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal Infection | 001 | 4 | NIH | 4/17/2026 | $259,181 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA248200 | Innovation in Measurement for Diet-Related Disease Research: Optimizing Utility and Reach to Reduce Health Disparities | 001 | 6 | NIH | 4/16/2026 | $19,005 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA276480 | Advanced Oncolytic Adenovirus Enabling Systemic Therapy of PDAC | 001 | 4 | NIH | 4/16/2026 | $35,457 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R21CA287351 | Characterize the metabolic landscape of ARID1A-mutated ovarian cancer | 001 | 2 | NIH | 4/16/2026 | $17,627 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | F30CA301797 | Targeting oncogenic KRAS to sensitize pancreatic cancer to NK cell immunotherapy | 002 | 1 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01HL163011 | Implications of PARP1 in myelodysplastic syndromes and targeted therapy | 000 | 5 | NIH | 4/17/2026 | $501,122 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA285620 | Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma. | 001 | 3 | NIH | 4/17/2026 | $48,598 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2221 UNIVERSITY AVE SE STE 100 | MINNEAPOLIS | MN | 55414-3074 | HENNEPIN | USA | R01CA277714 | Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life | 001 | 4 | NIH | 4/16/2026 | $34,859 |
|
